Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidoderm vs Celecoxib in Knee Osteoarthritis Pain
NCT00904605Phase 4Terminated
- Sponsor
- Endo International plc
- Start
- Jun 2004
- Primary completion
- Nov 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of lidocaine 10% oropharyngeal spray in osteoarthritis (OA) (2 arms), sponsored by Endo International plc. Primary endpoint: Western Ontario and McMaster Universities OA Index pain subscale at 12 weeks. Started Jun 2004; status: terminated.
02
Drugs
lidocaine 10% oropharyngeal spray
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT00904605.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00904605.